Moderna has announced the expansion of its US manufacturing capabilities with the onshoring of drug product manufacture to Massachusetts.

Regeneron has won two US Food and Drug Administration (FDA) approvals for Eylea HD (aflibercept), adding another indication ...

Novartis' two new sites in North Carolina fall under the Swiss pharma’s $23bn US manufacturing onshoring ploy.

Pfizer and Tris Pharma have agreed to pay $41.5m to settle allegations by the Texas Attorney General Ken Paxton ...

Mesenchymal stem cells have been explored across a wide range of diseases due to their potential to reduce inflammation and ...

Roche has conditional marketing authorisation from the EC for Lunsumio SC for adults with R/R FL after at least two systemic ...

CSL said the investment reflects the growing need for immunoglobulin, though it did not reveal detailed manufacturing plans.

Alkermes will likely proceed with its planned acquisition of Avadel, which experienced an unexpected hitch following Lundbeck ...

Redemplo’s approval in familial chylomicronemia syndrome places the drug in competition with Ionis’ Tryngolza.

The US FDA has granted approval for AbbVie’s Epkinly to treat adult patients with relapsed or refractory (R/R) follicular ...

Experts from Sharp offer insights into sustainable practices in pharma packaging, highlighting advancements achieved and ...

Eleva’s CEO says CHO cell line alternatives could become common in therapeutic protein manufacturing, as large molecule drugs become complex and harder to produce at scale.